XXXXX YYYYY, MPH, MS

EDUCATION
The Ohio State University June, 2012
- Master of Science
(Health Information Management)

- Master of Public Health June, 2011

(Epidemiology)

John Carroll University May, 2009

- Bachelor of Science, cum laude
(Biology)

SKILLS AND CERTIFICATIONS

 Expertise in population health, strategy, and data analysis for large health care organizations

 Leader in implementing strategic initiatives, new practice acquisitions, and marketing plans

 Department management, budget, and supervisory experience

 Development and assessment of quality metrics for evaluation of organizational success

 Leader in maintaining and overseeing accreditation status for various organizations

 Skilled in analyzing, illustrating, and using large (100,000+ patient) healthcare data sets for quality
improvement and executive level decision-making

 Extensive knowledge of healthcare data sources, metrics, and coding structures

 Software experience includes:

o Epic (EMR)
o REDCap (Database Design and Management)
o Tableau (Data Visualization)
o Microsoft Excel (Advanced)
o Microsoft Access (Basic)
o SPSS, STATA, SAS (Basic)

PROFESSIONAL AFFILIATIONS & AWARDS

 Adjunct Faculty, Southern New Hampshire University: January 2015 - Present
o Nominated for Distinguished Online Faculty (DOT) Award, 2019

 American College of Epidemiology (ACE): November 2017 - Present

 Council of State and Territorial Epidemiologists (CSTE): December 2015 - Present

EXPERIENCE
Manager, Cancer Health Analytics Top 5 Medical Center in US
August 2016 - Present

 Leads a department to support Cancer Center population health initiatives by gathering, analyzing, interpreting, and
presenting clinical and population-level data to the relevant stakeholders. Provides Institute Leadership with data
and recommends strategic opportunities.
 Develops and drives clinical improvement and efficiently strategies through analytics. Identifies opportunities for
improvement in patient access, experience, and quality. Initiatives include Cancer Data Warehouse, Care Pathway
development and assessment, Medicare Demonstration Projects such as the Oncology Care Model (OCM)/CMMI,
Time to Treatment/patient access pathways, Survivorship Care Plan, and estimating cancer market share for
oncology providers.

 Analyzes health information and data to provide insights and strategic opportunities to leadership. Develops best
practices and standards for managing data collection and reporting processes. Works to provide strategic vision,
leadership, and innovation with the design, development, and management of informatics, analytics, and
information technology to advance Service line.

 Leads and manages a 23-person department. Responsible for budget, educational activities and employee
development, enforcing policy and procedure, hiring, and corrective action for department. Obtains high
management level scores in PressGaney results.

 Ensures Commission on Cancer (CoC) and Cancer Incidence Surveillance System (OCISS) accreditation and
reporting requirements are met. Represents facility in developing the State Cancer Control Plan (OPCC).

 Creates visualizations of data appropriate to engage relevant audiences and stakeholders and facilitate decision-
making.

 Facilitates and coordinates research for healthcare populations through grant and proposal writing and scientific
abstract/paper publications.

 Maintains knowledge in the operation and management of tumor registries and national data guidelines (NAACR,
FORDS, SEER, NCDB, NCCN, NCI).

Program Manager III for Data Strategy & Integrity Top 5 Medical Center in US
June 2013 - July 2016

 Program manager for oncology data strategy and data integrity.

 Identified data collection needs and strategy for cancer programming across the enterprise. Responsible for
developing population-level analysis of clinical data to support research and enterprise-level decision-making.

 Lead the collection, analysis, and dissemination of data for Time to Treatment and Care Pathways for oncology
patients across the enterprise.

 Involved in daily operations of tumor registry- including reporting, analysis and Q/A of data, and adherence to
Commission on Cancer standards for accreditation.

 Conducted quantitative and qualitative analysis of cancer outcomes data, interprets and evaluates results of
analysis to be used for quality improvement of care, strategic planning, and decision-making.

 Oversaw validation of data from multiple databases and research studies into the Cancer Data Warehouse, a
master registry and research repository of all oncology patients at Main Campus. Maintains compliance and risk
management of research data sets.

 Selected, trained, and supervised administrative personnel. Manages daily staffing and activities.

Resource Planning Analyst The Ohio State University

Division of Thoracic Surgery/Tumor Registry April 2012 - June 2013
Columbus, Ohio
 Lead and managed data collection and the development, planning, and on-site administration of the Photodynamic
Therapy (PDT) Registry, a multi-center study with over seven active comprehensive cancer centers participating.

 Lead and managed the development, planning, and administration of the Robotic-Assisted Thoracic Surgery
(RATS) Registry to track outcomes of robotic thoracic surgery. Job duties included management of off-site study
coordinators, maintaining project budget and finances, obtaining and maintaining appropriate research permissions
(IRB, CSRC), and data entry, cleaning, and manipulation for publication.
 Developed and maintained collaborative relationships with medical and health system staff to ensure effective,
results-oriented project outcomes, and consulted with and advised in the development of integrated relational
databases and knowledge systems to facilitate future outcomes projects using secondary data.

Epidemiologist I Ohio Department of Health

Bureau of Infectious Disease January 2011 - April 2012
Columbus, Ohio
 Investigator of influenza hospitalizations in a 7-county area surrounding Columbus, Ohio. Responsibilities included
medical record review and data abstraction, use of statewide disease reporting database, input and organization of
information to the CDC, and analysis of influenza trends state and nationwide.

Project Manager The Ohio State University

College of Nursing, Clinical Research September 2010 - April 2012
Columbus, Ohio
 Project manager to a clinical pilot study investigating a support intervention for shared decision-making about
depressive symptoms in type II Diabetes Mellitus patients. Tasks included data collection, patient interviews, data
cleaning and manipulation, and qualitative and quantitative analyses to prepare for publication of the study, as well
as preparing for an R01 grant application to fund further research.

Environmental Health & Vector Control Specialist Cuyahoga County Board of Health
Parma, Ohio May 2008 - August 2008

 Responsible for the protection of Cuyahoga County residents from vector-borne disease (mosquitos, ticks, bats,
raccoons). Disseminated biological control county-wide, educated county residents, and evaluated/mitigated
potential reservoirs of disease.

PUBLICATIONS
 Sittenfeld SMC, Moore HCF, Greenberg Z, Al-Hilli Z, Abraham J, Grobmyer S, Montelone E, , Shah C. The power of one:
Evaluating the impact of a single multi-dsciplinary treatment visit on time to treatment. The Breast Journal, in press, 2020.

 Khorana AA, , Elson P, Pennell NA, Grobmyer SR, Kalady MF, Raymond D, Abraham J, Klein EA, Walsh RM, Monteleone EE,
Wei W, Hobbs B, Bolwell BJ. Time to initial cancer treatment in the United States and association with survival over time:
an observational study. PLOS ONE 14(2019):e0213209.

 Khunger M, Rakshit S, , Galsky M, Hernandez Dias AV, Pasupuleti V, Grivas P. Premature clinical trial discontinuation in
the era of immune checkpoint inhibitors. The Oncologist 23(2018):1494-1499.

 Kozak VN, Khorana AA, Amaranth S, , Kalady MF. Multidisciplinary clinics for colorectal cancer care reduces treatment
time. Clinical Colorectal Cancer, 16(2017):366-371.

 Fillion M, , Hayek J, Wehr A, Phillips G, Agnese D. Healthcare costs reduced after incorporating the results of the American
College of Surgeons Oncology Group (ACOSOG) Z0011 trial into clinical practice. The Breast Journal, 23(2017):275-281.

 Adelstein DA, Koyfman S, Houston N, , Lamarre E, Scharpf J, Lorenz R, Khan M, Nwizu T, Greskovich J, Ives D, Rahe M,
Bodmann J, Harr B, Bolwell B. Successful development, implementation, and assessment of a clinical care path (CP)
guide for the treatment of HPV-initiated oropharynx cancer. International Journal of Radiation Oncology, Biology, Physics
94(2016).

 Parekh HD, , Elson P, Davis MP, Velcheti V, Stevenson J, Shapiro MA, Carrino CM, Pennell NA. The effect of routine early
palliative care (PC) consultation on aggressiveness of care at the end of life (EOL) in patients with advanced non-small
cell lung cancer (NSCLC). Journal of Clinical Oncology 34(2016):e21688.

 Reu FJ, Radivoyevitch T, Valent J, Cummings C, , Hastings D, Faiman BM, Hamilton K, Reed J, Karam MA, Kalaycio M, Lieu
HK, Samaras C, Bolwell BJ, Smith MR. Response-adapted therapy for newly diagnosed myeloma. Blood, 128(2016): 3606.

 Van Loon K, Zhang L, Keiser J, Carrasco C, , Ramirez MT, Bobiak S, Nakaura EK, Venook AP, Shah MH, Bergsland EK. Bone
metastases and skeletal-related events from neuroendocrine tumors. Endocrine Connections 4(2015): 9-17.
 Sohal DP, Shotriya S, , Pelley RJ, McNamara MJ, Estfan B, Shapiro M, Wey J, Chalikonda S, Morris-Stiff G, Walsh RM, Khorana
AA. Predicting early mortality in resectable pancreatic adenocarcinoma: a cohort study. Cancer, 121(2015):1779-1884.

 , Wills CE, Holloman C, Olson J, Hechmer C, Miller CK, Duchemin AM. Shared decision making and other variables as
correlates of satisfaction with health care decisions in a United States national survey. Patient Education and Counseling,
88(2012): 100-105.

PRESENTATIONS
 . Building and maintaining a cancer survivorship/follow-up care program that meets the Commission on Cancer
Standard. American College of Surgeons Quality and Safety Conference, Washington D.C. July, 2019.

 Urbanek D, . A CRM solution for navigating patients through the health system. Northern Ohio Health Information and
Management Systems Society (NOHIMSS) Fall Conference, Cleveland, Ohio. November, 2017.

 Urbanek D, . Gaining actionable insights faster by leveraging the data lab environment. Healthcare Data and Analytics
Association (HDAA) Conference, Cleveland, Ohio. November, 2017.

 Keshava HB, Sinopoli J, Murthy S, Raja S, Stevenson J, Bakaeen F, , Ahmad U. Is Pleural Mesothelioma in our rear-view
mirror? An examination of contemporary trends in disease presentation and management. 41st Annual Meeting of VA
Surgeons, Houston, Texas. May, 2017.

 . Patient Perceptions of Electronic Health Records (EHRs) in Outpatient Healthcare Visits: A Survey of the State of Ohio.
Northeast Ohio Health Information Management (NOHIMA) Meeting October, 2016.

 Fillion M, , Wehr A, Phillips G, Wilson JL, Farrar W, Agnese D. Practice habits changes after the results of the American
College of Surgeons Oncology Group (ACOSOG) Z0011 trial. 24th Annual Presidential Symposium of the Columbus Surgical
Society, Columbus, Ohio. March 2013.

 Ross P, Bechara R, Cerfolio RJ, Fuller CB, Pennathur A, Wahidi M, Skabla PL, , Wilson JL. Cancer centre collaboration to
establish outcomes in photodynamic therapy. 9th International Symposium on Photodynamic Therapy and Photodiagnosis
in Clinical Practice, South Tyrol, Italy. October 2012.

 , Wills CE, Holloman C, Olson J, Hechmer C, Miller CK, Duchemin AM. Shared decision making and other variables as
correlates of satisfaction with health care decisions in a United States national survey. 6th International Shared Decision
Making Conference, Maastricht, The Netherlands. June 2011.

 Wills CE, , Holloman C, Hechmer C, Miller C, Belury M, Duchemin AM, Miser W. Validation of the SDM Questionnaire-9
(SDM-Q-9) in a stratified age-proportionate U.S. sample. 6th International Shared Decision Making Conference, Maastricht,
The Netherlands. June 2011.

POSTERS
 Kamath SD, Wei W, , Cooper GS, Khorana AA. Effect of shorter time to treatment on survival in rural patients with breast
cancer. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois. June, 2020.

 Nair KG, Wei W, Cruise M, , Estfan B. Outcomes of appendiceal adenocarcinomas compared to right and left-sided
colorectal adenocarcinomas: an analysis from the National Cancer Database (NCDB). American Society of Clinical
Oncology (ASCO) Gastrointestinal Cancers Symposium; San Francisco, California. January, 2020.

 Rothacker A, . Reducing administrative burden through the use of IT tools. American Society of Clinical Oncology (ASCO)
Quality Care Symposium; San Diego, California. September, 2019.

 , Seals A, Boucher C, Anderson N, Sanders K, Bell K. Patient navigation (PN) For colorectal cancer screening (CRC):
experience in program implementation for underserved neighborhoods of Cleveland, Ohio. American Society of Clinical
Oncology (ASCO) Quality Care Symposium; San Diego, California. September, 2019.

 Harr BA, Boadmann J, , Tackitt H. Evolution of a survivorship program: The Cleveland Clinic experience. National
Comprehensive Cancer Network (NCCN) Annual Conference, Orlando, Florida. March, 2019.

 Wee CE, Radivoyevitch T, Jia X, Khorana AA, , Stevenson JP. Time to treatment initiation and outcomes in malignant
mesothelioma: an NCDB review. International Conference of the International Mesothelioma Interest Group, Ottawa, Canada.
May, 2018.
 Chen YW, , Ornstein MC, Grivas P, Garcia GA, Rini BI. The impact of facility case volume on overall survival in patients
with metastatic renal cell carcinoma in the targeted therapy area. American Society of Clinical Oncology (ASCO)
Genitourinary Cancers Symposium, San Francisco, California. February, 2018.

 Makkar V, Radford DM, Leinweber J, Obi E, Obi E, . Adherence and efficacy of neoadjuvant care paths in a community
hospital. National Consortium of Breast Centers (NCBC) Annual Breast Cancer Conference, Las Vegas, Nevada. March, 2018.

 Sawalha Y, Radivoyevitch T, , Dean RM, Pohlman B, Hill BT, Kalaycio M, Majhail NS, Jagadeesh J. The role of upfront
autologous hematopoietic cell transplantation in the treatment of mantle cell lymphoma, a population based study
using the National Cancer Data Base (NCDB). 59th American Society of Hematology (ASH) Annual Meeting & Exposition,
Atlanta, Georgia. December, 2017.

 Khorana AA, , Elson P, Pennell NA, Raymond D, Klein E, Abraham J, Grobmyer S, Kalady M, Monteleone EE, Bolwell B. Delays
in initiating cancer therapy are increasing, and associated with worsened survival in curative settings: A US analysis
of common solid tumors. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois. June, 2017.

 Combs S, , Elson P, Pennell NA. Association of delays in time to surgery for resectable stage IIIA non-small cell lung
cancer with survival. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois. June, 2017.

 Koshkin VS, Barata PC, Zahoor H, Rybicki LA, Emamekhoo H, Almassi N, , Redden AM, Fergany AF, Kaouk J, Haber GP,
Beach J, Martin A, Allman KD, Garcia JA, Gilligan TD, Rini BI, Grivas P. Cisplatin-based neoadjuvant chemotherapy (NAC)
in bladder cancer patients (Pts) with borderline renal cell function: Implications for clinical practice. American Society
of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Orlando, Florida. February, 2017.

 Khunger M, Rakshit S, , Galsky MD, Grivas P. Premature clinical trial discontinuation in all and genitourinary cancers in
the era of Immune Checkpoint Inhibitors (ICI). American Society of Clinical Oncology (ASCO) Genitourinary Cancers
Symposium, Orlando, Florida. February, 2017.

 Sohal DE, Altujjar M, , Abazeed M, Pelley RJ, McNamara MJ, Estfan BN, Shapiro MA, Korana AA. Clinical outcomes in
borderline resectable pancreatic cancer: A cohort study. American Society of Clinical Oncology (ASCO) Gastrointestinal
Cancers Symposium, San Francisco, California. January, 2017.

 Hong S, Varella L, , Moore HCF, Budd GT, Grobmyer SR, Montero AJ, Schnur G, Abraham J. Use of imaging studies for
early-stage breast cancer at Cleveland Clinic. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago,
Illinois. June, 2016.

 , Cummings CW, Shapiro MA, Urbanek D, Bolwell BJ. Data collection for care pathways in the Cleveland Clinic Health
System. American Society of Clinical Oncology (ASCO) Quality Conference, Phoenix, Arizona. February, 2016.

 Shapiro MA, , Redden AM, Pennell NA, Stevenson J, Velcheti V, Van Wagoner E, Cummings CW, Bolwell BJ. Patient-centered
outcomes with post-approval nivolumab in metastatic NSCLC at the Cleveland Clinic Taussig Cancer Institute (TCI).
American Society of Clinical Oncology (ASCO) Quality Conference, Phoenix, Arizona. February, 2016.

 Cummings CW, Kenney R, , Monteleone EE, Bolwell BJ. Applying value stream mapping to improve patient flow and
satisfaction. American Society of Clinical Oncology (ASCO) Quality Conference, Phoenix, Arizona. February, 2016.

 Mi K, McNamara MJ, Jia X, Sawalha Y, , Khorana AA. Outcomes after resection of pulmonary metastases in patients with
colorectal cancer. American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, San Francisco,
California. January, 2016.

 Winter A, Raska P, Ornstein M, Moore H, Montero A, Buddy GT, , Bailey J, Abraham J. Socioeconomic characteristics of
African American women with breast cancer. San Antonio Breast Conference Symposium, San Antonio, Texas. December,
2015.

 Raska P, Ott MA, Steele A, Bailey A, Hickman D, Allen D, Urbanek D, , Bailey J, Bell K, Montero A, Abraham J. Healthcare
barrier profiles in patients navigated for cancer screening and treatment and the impact of the Affordable Care Act. San
Antonio Breast Conference Symposium, San Antonio, Texas. December, 2015.

 Valent J, Samaras C, Hastings, D, Fairman BM, Hamilton K, Bolwell BJ, Reed J, Karam MA, Cummings C, , Smith MR, Hien
KL, Reu FJ. Response adapted induction therapy for multiple myeloma. 57th American Society of Hematology (ASH) Annual
Meeting & Exposition, Orlando, Florida. December, 2015.

 Mi M, McNamara MJ, Elson P, Shrotiya S, , Quintini C, Aucejo F, Berber E, Khorana AA. Benefit of perioperative systemic
therapy in patients with colorectal liver metastases (CRLM) undergoing liver-directed therapy (LDT). American Society
of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois. June, 2015.

 Shapiro M, Stevenson J, Van Wagoner E, , Cummings C, Pennell N, Ma P, Velcheti V, Bastos B, Haddad A, Bolwell B. Impact
of a Stage IV NSCLC care pathway on front-line (FL) and maintenance (M) chemotherapy use at the Cleveland Clinic
Taussig Cancer Institute (TCI). American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois. June, 2015.
 . Patient perceptions of Electronic Health Records (EHRs) in outpatient healthcare visits: a survey of the state of Ohio.
5th Patient Experience Summit, Cleveland, Ohio. May, 2014.

 Van Loon K, Zhang L, Keiser J, Carrasco C, , Ramirez MT, Bobiak S, Nakaura EK, Venook AP, Shah MH, Bergsland EK.
Clinical presentation and management of patients with bone metastases and skeletal-related events from
neuroendocrine tumors. Meeting of the North American Neuroendocrine Tumor Society (NANETS), Charleston, South
Carolina. October, 2013.

 Ross P, Skabla PL, Kassis E, Moffatt-Bruce S, , Daniel V. Robotic-assisted lobectomy: a platform for increasing minimally
invasive pulmonary resections. 15th World Conference on Lung Cancer (International Association for the Study of Lung
Cancer), Sydney, Australia. October, 2013.

 Olson J, Wills CE, Gideon V, . Association of adverse childhood experiences and perceived autonomy support with
diabetes-related distress among adults with diabetes mellitus and depressive symptoms. 37th Annual Midwest Nursing
Research Society Conference, Chicago, Illinois. March, 2013.

 Wu C, Wei L, , Wilson JW, Arnold M, Harzman A, Husain S, Schmidt C, Abdel-Misih S, Goldberg RM, Bekaii-Saab T. Analysis
of survival benefit of adjuvant chemotherapy for patients with resected rectal cancers who have received neoadjuvant
chemoradiation. ASCO Gastrointestinal Cancers Symposium, San Francisco, California. January 2013.